CINECA IRIS Institutional Research Information System

FIERRO, Maria Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.397
EU - Europa 8.076
AS - Asia 3.548
SA - Sud America 199
OC - Oceania 97
AF - Africa 89
Continente sconosciuto - Info sul continente non disponibili 36
Totale 22.442
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.080
CN - Cina 1.909
IT - Italia 1.842
IE - Irlanda 940
DE - Germania 822
FR - Francia 795
SE - Svezia 697
KR - Corea 592
UA - Ucraina 508
GB - Regno Unito 472
FI - Finlandia 453
JP - Giappone 326
AT - Austria 301
ES - Italia 297
CA - Canada 263
PL - Polonia 230
IN - India 224
VN - Vietnam 113
CH - Svizzera 110
DK - Danimarca 107
NL - Olanda 89
BR - Brasile 88
AU - Australia 79
HK - Hong Kong 66
BE - Belgio 64
GR - Grecia 58
TR - Turchia 58
PT - Portogallo 56
SG - Singapore 54
IL - Israele 52
RU - Federazione Russa 49
SN - Senegal 46
MX - Messico 44
RO - Romania 40
EU - Europa 36
AR - Argentina 34
NO - Norvegia 30
TW - Taiwan 29
CO - Colombia 25
CZ - Repubblica Ceca 24
CL - Cile 23
HU - Ungheria 22
SA - Arabia Saudita 22
PE - Perù 19
NZ - Nuova Zelanda 18
PH - Filippine 18
SI - Slovenia 16
TH - Thailandia 13
IR - Iran 12
EG - Egitto 10
ID - Indonesia 10
MY - Malesia 10
BG - Bulgaria 8
MA - Marocco 7
NG - Nigeria 7
SK - Slovacchia (Repubblica Slovacca) 7
UZ - Uzbekistan 7
EC - Ecuador 6
MK - Macedonia 6
RS - Serbia 6
ZA - Sudafrica 6
AL - Albania 5
EE - Estonia 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
BY - Bielorussia 4
CR - Costa Rica 4
HR - Croazia 4
JO - Giordania 4
KW - Kuwait 4
PK - Pakistan 4
QA - Qatar 4
HN - Honduras 3
KE - Kenya 3
LK - Sri Lanka 3
PA - Panama 3
AD - Andorra 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
GF - Guiana Francese 2
IQ - Iraq 2
LB - Libano 2
MN - Mongolia 2
MU - Mauritius 2
AM - Armenia 1
CY - Cipro 1
DZ - Algeria 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MT - Malta 1
NP - Nepal 1
SM - San Marino 1
TZ - Tanzania 1
UG - Uganda 1
Totale 22.442
Salva come PNG Salva come JPEG
Città #
Chandler 1.578
Beijing 1.221
Dublin 935
Houston 427
Ashburn 414
Fairfield 408
Jacksonville 381
Princeton 361
Villeurbanne 360
Medford 348
Torino 333
Ann Arbor 308
Wilmington 272
Redwood City 259
Vienna 247
Nyköping 242
Dearborn 209
Woodbridge 204
Warsaw 192
Seattle 173
Cambridge 165
Milan 165
Boston 124
Pisa 102
New York 99
Shanghai 90
Toronto 83
Tokyo 82
Pune 77
Washington 73
Dong Ket 70
Boardman 67
Turin 60
Madrid 54
Duncan 53
Fremont 53
Guangzhou 52
Nanjing 51
Paris 50
Rome 48
Norwalk 47
London 45
Verona 45
Hebei 42
Hangzhou 38
Hefei 37
Barcelona 35
Berlin 35
Bologna 35
Brussels 34
Philadelphia 34
Chengdu 33
Seoul 33
San Diego 32
Helsinki 31
Ottawa 30
Falls Church 28
Zurich 28
Athens 27
Chicago 27
São Paulo 27
Rochester 26
Singapore 26
Mountain View 25
Shenyang 25
Jinan 23
Munich 22
Napoli 22
Copenhagen 21
Hamburg 21
Kunming 20
Lachine 20
Leiden 20
Central 19
Istanbul 19
Baltimore 18
Columbus 18
Los Angeles 18
Tianjin 18
Zhengzhou 18
Phoenix 17
San Mateo 17
Taipei 17
Tampa 17
Brooklyn 16
Mumbai 16
Pavia 16
Silver Spring 16
Valencia 15
Lima 14
Saluzzo 14
Bucharest 13
Dallas 13
Hong Kong 13
Lisbon 13
Nanchang 13
Redmond 13
Santiago 13
Sydney 13
Wuhan 13
Totale 11.904
Salva come PNG Salva come JPEG
Nome #
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial 3.628
Prognostic role of Histologic regression in primary cutaneous melanoma: A Systematic Review and Meta-analysis 484
Blood Flow Cytometry in Sézary Syndrome: New Insights on Prognostic Relevance and Immunophenotypic Changes During Follow-up. 428
Spiky follicular mycosis fungoides: a clinicopathologic study of 8 cases. 290
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study 289
Intestinal involvement in toxic epidermal necrolysis. A case report and review of literature. 287
Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients. 278
Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients [*MT. Fierro and AMC Cuffini contributed equally to this work] 259
Atopic dermatitis in a phenylketonuric untreated patient 247
Metastasi ossee da melanoma: incidenza e impatto sulla sopravvivenza 240
Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years. 239
Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome 233
Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review 232
Giornale italiano di Dermatologia e Venereologia 224
Functional and Phenotypical Impairment of Polymorphonuclear Cells in Atopic Dermatitis: An Additional Cause for the Known Susceptibility to Infections? [*M.T. Fierro and G. Banche contributed equally to this work] 219
Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role? 208
Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172) 208
Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology group 203
Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas 198
HPyV6, HPyV7 and TSPyV DNA sequences detection in skin disease patients and healthy subjects. 198
BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody 187
Alterazioni funzionali e fenotipiche dei polimorfonucleati nella sindrome di sezary 175
Malattia di Castleman multicentrica associata a sarcoma di Kaposi Savoia P, Fierro MT, Quaglino P, Zaccagna A, Bernengo MG 172
High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease. 170
Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients. 164
Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp 147
Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectives 142
Metastatic sebaceous cell carcinoma, review of the literature and use of electrochemotherapy as possible new treatment modality 140
Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood 136
Rischio di recidiva ed intervallo libero da malattia: linee guida di terapia e follow-up. 127
miR-155 expression in Primary Cutaneous T-Cell Lymphomas (CTCL) 126
Prognostic differences across sexes in melanoma patients: What has changed from the past? 120
Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status: A Systematic Review and Meta-analysis 115
The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis. 115
A novel leukemia T-cell line (PF-382) with phenotypic and functional features of suppressor lymphocytes. 112
Alterazioni funzionali e fenotipiche dei polimorfonucleati nei pazienti affetti da dermatite atopica 109
Fotoferesi: applicazioni terapeutiche “off-label” 107
Studio citofluorimetrico della popolazione circolante CD4+CD27+ nelle eritrodermie infiammatorie e nei linfomi cutanei: relazione con i livelli di cellule CD4+CD26- ed utilità diagnostica. 105
Flow-cytometry and functional evaluation of the CD39/CD73 adenosinergic immunosuppressive axis in patients with Sézary syndrome 104
TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk 103
Associazione di etoposide, idarubicina, ciclofosfamide, vincristina, prednisone e bleomicina (VICOP-B) nel trattamento dei linfomi cutanei 100
Alemtuzumab for the treatment of Sézary sindrome: clinical and immunological findings in 10 patients. 96
Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role 95
ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas 94
Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients. 91
Fluorescence-Advanced-Videodermatoscopy (FAV): a new method for in-vivo skin evaluation 91
'Aleukemic' granulomatous leukemia cutis. 89
Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers. 89
Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin. 87
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. 87
Treatment of metastatic melanoma: a multidisciplinary approach 87
Interleuchina-2 e Interferone-gamma nella leucemia linfatica cronica a cellule B 85
Genotypic characterization of common acute lymphoblastic leukemia may improve the phenotypic classification. 84
Immunoregulatory T-cell defects in B-cell chronic lymphocytic leukemia: cause or consequence of the disease? The contributory role of decreased availability of interleukin 2 (IL-2). 83
Abstract 5603: Melanoma PD1 expression is upregulated by MAPK inhibitors leading to an immune-independent synergism with anti-PD1 antibodies 83
Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population. 81
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: A multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium 80
Virus di Epstein-Barr e linfomi primitivi cutanei: valutazione della carica virale mediante PCR quantitativa-competitiva (QC-PCR) su biopsia. 80
Immature T lymphocytes in human cord blood identified by monoclonal antibodies: a model for the study of the differentiation pathway of T cells in humans. 79
[Effect of human plasma on the in vitro formation of T-lymphocyte colonies] 79
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. 79
Associazione di ciclofosfamide, vincristina e prednisone (COP) nel trattamento dei linfomi cutanei: 20 anni di follow-up. 78
Arrhythmias in metastatic melanoma patient treated with targeted therapy and ICD implant. 78
Normal helper T-cell function in hairy-cell leukaemia. 78
Chronic T-cell leukaemias. III. T-colonies, PHA response and correlation with membrane phenotype. 76
Chronic T-cell leukaemias. A variant of T-prolymphocytic leukaemias: morphological, immunological and clinical characterization of 2 cases 76
Low-dose intermittent Alemtuzumab in Sézary Syndrome: clinical activity, toxicity profile and immunological findings in 17 patients. 76
Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients. 76
Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34-year single-institution study 75
Clonal heterogeneity in mycosis fungoides/Sézary Syndrome: incidence, relation with clinico-pathologic features and prognostic significance 75
Evaluation of PMNs functional and phenotypical alterations in mycosis fungoides patients. 75
Electrochemotherapy in treatment of skin melanoma metastases 75
Un caso di leucemia/linfoma a cellule T dell'adulto con localizzazioni cutanee: caratteristiche cliniche, istologiche ed immunologiche 74
Autoimmune connective tissue diseases and pregnancy 73
1975-2011 Overall Survival, Disease Free Survival and Survival after Recurrence across gender in melanoma patients: what has changed? 73
Different stages of B cell differentiation in non-T acute lymphoblastic leukemia 73
Immunotherapy in Xeroderma Pigmentosum: A case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review 73
CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients. 71
CD26 (DPP-IV)- A useful marker in Sezary sindrome 71
PCR Real time Mismatch Amplification Mutation Assay (MAMA Real Time PCR) for evaluation of TNFα promoter gene polymorphism -308 G/A in patients with psoriasis. 71
Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevance 69
Le infezioni nella micosi fungoide e nella sindrome di Sézary 69
Multivariate analysis of prognostic factors in 58 Sézary syndrome patients 69
Caratterizzazione immunoistochimica e citofluorimetrica di una nuova linea di melanoma. 69
Alemtuzumab nel trattamento dei linfomi cutanei a cellule T in fase avanzata: studio pilota “dose finding”. 68
Quantificazione mediante PCR dell’EBV-DNA da biopsie cutanee di pazienti con CTCL (micosi fungoide e sindrome di Sezary) 68
CD26 expression on cutaneous infiltrates from patients CD26 expression on cutaneous infiltrates from patients with cutaneous T-cell lymphoma (CTCL) CD26 in cutaneous T-cell lymphoma patients. 67
Clinical significance of sequential tyrosinase expression in the peripheral blood of disease-free melanoma patients: a review of literature data 67
TCRgamma-chain gene rearrangement by GeneScan: incidence and significance of clonal heterogeneity in Sézary syndrome. 67
Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features. 66
Efficacy of electrochemotherapy for eruptive legs keratoacanthomas 66
B-chronic lymphocytic leukaemia patients with stable benign disease show a distinctive membrane phenotype. 66
Bullous, cutaneous, pleomorphic T-cell Lymphoma: analysis of integrins and extracellular matrix components. 66
Immunotherapy in transplanted patients: A special population that can no longer be ignored 66
Pinocchio cells: morphologically atypical immunologically heterogeneous lymphocytes induced by treatment with interleukin 2. 65
Treatment of hairy-cell leukaemia with alpha-interferon (alpha-IFN). 65
Phenotypical and functional alterations of polymorphonucleates in sezary syndrome patients 65
A human leukemic T cell line (PF-382) inhibits the growth of myeloid and erythroid progenitor cells. 64
Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients 64
Peripheral blood and bone marrow immunophenotypic and functional modifications induced in acute leukemia patients treated with interleukin 2: evidence of in vivo lymphokine activated killer cell generation. 63
Totale 15.833
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.282
article - articoli 0
book - libri 0
conference - conferenze 12.957
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.239
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019743 0 0 0 0 0 0 0 0 0 197 364 182
2019/20203.125 141 115 154 288 223 407 385 273 346 296 265 232
2020/20212.555 326 158 181 157 232 205 185 130 263 249 210 259
2021/20223.344 165 135 182 194 278 156 224 227 183 221 616 763
2022/20235.150 584 391 170 428 500 1.121 424 331 549 196 275 181
2023/20242.301 343 411 227 220 213 353 154 196 49 135 0 0
Totale 23.297